Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 20:00
Amgen Price to Book Value : 20.53 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.32 |
| August 20, 2026 | 20.06 |
| August 19, 2026 | 20.46 |
| August 18, 2026 | 19.67 |
| August 17, 2026 | 19.40 |
| August 14, 2026 | 19.20 |
| August 13, 2026 | 19.33 |
| August 12, 2026 | 19.25 |
| August 11, 2026 | 19.16 |
| August 10, 2026 | 19.30 |
| August 07, 2026 | 19.01 |
| August 06, 2026 | 18.73 |
| August 05, 2026 | 18.86 |
| August 04, 2026 | 18.04 |
| August 03, 2026 | 17.52 |
| July 31, 2026 | 17.81 |
| July 30, 2026 | 17.93 |
| July 29, 2026 | 17.93 |
| July 28, 2026 | 18.18 |
| July 27, 2026 | 17.40 |
| July 24, 2026 | 17.39 |
| July 23, 2026 | 17.18 |
| July 22, 2026 | 16.93 |
| July 21, 2026 | 16.94 |
| July 20, 2026 | 16.84 |
| Date | Value |
|---|---|
| July 17, 2026 | 16.94 |
| July 16, 2026 | 17.19 |
| July 15, 2026 | 16.57 |
| July 14, 2026 | 16.43 |
| July 13, 2026 | 16.67 |
| July 10, 2026 | 16.81 |
| July 09, 2026 | 16.82 |
| July 08, 2026 | 17.02 |
| July 07, 2026 | 17.03 |
| July 06, 2026 | 16.95 |
| July 02, 2026 | 17.31 |
| July 01, 2026 | 16.71 |
| June 30, 2026 | 16.75 |
| June 29, 2026 | 21.17 |
| June 26, 2026 | 21.04 |
| June 25, 2026 | 20.72 |
| June 24, 2026 | 20.64 |
| June 23, 2026 | 20.38 |
| June 22, 2026 | 20.24 |
| June 18, 2026 | 19.83 |
| June 17, 2026 | 20.06 |
| June 16, 2026 | 20.43 |
| June 15, 2026 | 20.59 |
| June 12, 2026 | 20.86 |
| June 11, 2026 | 20.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.40 |
| Regeneron Pharmaceuticals, Inc. | 2.702 |
| AbbVie, Inc. | -- |
| Biogen, Inc. | 1.709 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
Price to Book Value Related Metrics
| PE Ratio | 27.57 |
| PS Ratio | 6.312 |
| PEG Ratio | 0.8696 |
| Price to Free Cash Flow | 23.70 |
| Price | 443.84 |
| Earnings Yield | 3.63% |
| Market Cap | 239.94B |
| PEGY Ratio | 0.8117 |
| Operating PE Ratio | 18.95 |
| Normalized PE Ratio | 25.16 |